Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgical Pathology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Epstein-barr virus sequence variation-biology and disease.Pathogens. 2012; 1: 156-174
- Epstein-Barr virus strain variation and cancer.Cancer Sci. 2019; 110: 1132-1139
- Latent and lytic Epstein-Barr virus replication strategies.Rev Med Virol. 2005; 15: 3-15
- The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity.Nat Commun. 2022; 13: 187
- How I treat EBV lymphoproliferation.Blood. 2009; 114: 4002-4008
- Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.J Exp Med. 1998; 187: 1395-1402
- Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens.Blood. 2000; 95: 241-248
- Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.Blood. 2005; 106: 4339-4344
- Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.Nature. 1995; 375: 685-688
- Ebna1. Curr Top Microbiol Immunol. 2015; 391: 3-34
- EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.Semin Cancer Biol. 2001; 11: 423-434
- Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.J Clin Invest. 1997; 100: 2961-2969
- Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.Proc Natl Acad Sci U S A. 1998; 95: 11963-11968
- Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.J Virol. 1999; 73: 9827-9831
- Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.Mod Pathol. 2021; 34: 2154-2167
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia. 2022; 36: 1720-1748
- EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.Am J Clin Pathol. 2017; 147: 129-152
- B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.Am J Clin Pathol. 2017; 147: 153-170
- Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?.Blood. 2018; 132: 1871-1878
- Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.Mod Pathol. 2005; 18: 519-527
- EBV-encoded RNA1-positive cells in the bone marrow specimens of patients with EBV-negative lymphomas and sarcomas.Pathol Int. 2019; 69: 392-397
- EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.Am J Surg Pathol. 2010; 34: 405-417
- The Spectrum of EBV-Positive Mucocutaneous Ulcer: A Study of 9 Cases.Am J Surg Pathol. 2019; 43: 201-210
- A case of EBV-associated blastic lymphoplasmacytic proliferation in an oesophageal ulcer with a self-limiting course: overlapping lesion between EBV mucocutaneous ulcer and polymorphic lymphoplasmacytic disorder.Histopathology. 2019; 74: 964-966
- EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.Blood. 2015; 126: 863-872
- An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma.Blood. 2019; 134: 591-596
- Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.N Engl J Med. 1989; 320: 689-695
- Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.Blood. 2012; 120: 3750-3755
- A cohort study of cancer following infectious mononucleosis.Cancer Res. 1974; 34: 1172-1178
- Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience.Br Med J. 1974; 2: 253-256
- Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma.Cancer Res. 2007; 67: 2382-2388
- Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study.Blood. 2005; 106: 2444-2451
- Immunodeficiency-associated Hodgkin lymphoma.Expert Rev Hematol. 2021; 14: 547-559
- HIV-associated Burkitt lymphoma.Lancet Haematol. 2020; 7: e594-e600
- Epstein-Barr virus-positive follicular lymphoma.Mod Pathol. 2017; 30: 519-529
- Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma.Am J Hematol. 2019; 94: E62-E64
- Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings.Am J Surg Pathol. 2018; 42: 1306-1316
- EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?.Am J Surg Pathol. 2011; 35: 807-815
- Diffuse large B-cell lymphoma variants: an update.Pathology. 2020; 52: 53-67
- Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation.Am J Surg Pathol. 2017; 41 (PMID: 28195879): 299-312https://doi.org/10.1097/PAS.0000000000000775
- Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders.Am J Transplant. 2013; 13: 1305-1316
- EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.Mod Pathol. 2012; 25: 968-982
- NF-kappaB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas.Nucleic Acids Res. 2014; 42: 11025-11039
- Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-kappaB activation.J Virol. 2012; 86: 11096-11106
- EBV-positive B-cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency.Cancer Med. 2021; 10: 6777-6785
- EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.Br J Haematol. 2021; 194: 870-878
- Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma.Genes Chromosomes Cancer. 2015; 54: 383-396
- 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions.Am J Surg Pathol. 2022; 46: 1017-1024
- PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.Clin Cancer Res. 2013; 19: 3462-3473
Article info
Publication history
Published online: March 10, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
